These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 15569492)

  • 1. Clinical significance of N-terminal pro-brain natriuretic peptide.
    Zhang XY; Zhu JH
    Chin Med J (Engl); 2004 Nov; 117(11):1716-22. PubMed ID: 15569492
    [No Abstract]   [Full Text] [Related]  

  • 2. [Heart failure. Diagnosis and prognosis readable from a simple blood test].
    MMW Fortschr Med; 2004 Mar; 146(11):59. PubMed ID: 15152779
    [No Abstract]   [Full Text] [Related]  

  • 3. Usefulness of N-terminal-pro-brain natriuretic peptide levels in predicting survival in heart transplant recipients.
    Ambrosi P; Oddoze C; Ribéri A; Arques S; Portugal H; Métras D; Habib G
    Am J Cardiol; 2004 Dec; 94(12):1585-7. PubMed ID: 15589026
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Long reach of the N-terminal of B-type natriuretic peptide.
    SoRelle R
    Circulation; 2002 Dec; 106(23):e9059. PubMed ID: 12460860
    [No Abstract]   [Full Text] [Related]  

  • 5. The extent of myocardial damage assessed by contrast-enhanced MRI is a major determinant of N-BNP concentration after myocardial infarction.
    Cochet A; Zeller M; Cottin Y; Robert-Valla C; Lalande A; L'Huilllier I; Comte A; Walker PM; Desgres J; Wolf JE; Brunotte F
    Eur J Heart Fail; 2004 Aug; 6(5):555-60. PubMed ID: 15302002
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Plasma N-terminal pro-B-type natriuretic peptide for prediction of death or nonfatal myocardial infarction following percutaneous coronary intervention.
    de Winter RJ; Stroobants A; Koch KT; Bax M; Schotborgh CE; Mulder KJ; Sanders GT; van Straalen JP; Fischer J; Tijssen JG; Piek JJ
    Am J Cardiol; 2004 Dec; 94(12):1481-5. PubMed ID: 15589000
    [TBL] [Abstract][Full Text] [Related]  

  • 7. N-terminal probrain natriuretic peptide as a predictor of short-term outcomes in acute myocardial infarction.
    Puri A; Narain VS; Mehrotra S; Dwivedi SK; Saran RK; Puri VK
    Indian Heart J; 2005; 57(4):304-10. PubMed ID: 16350675
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Warning! Context-sensitive data.
    Mills RM
    J Am Coll Cardiol; 2005 Feb; 45(4):542-3. PubMed ID: 15708701
    [No Abstract]   [Full Text] [Related]  

  • 9. Amino-terminal pro-brain natriuretic peptide: a biomarker for diagnosis, prognosis and management of heart failure.
    Morello AM; Januzzi JL
    Expert Rev Mol Diagn; 2006 Sep; 6(5):649-62. PubMed ID: 17009901
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Risk assessment in patients with unstable angina/non-ST-elevation myocardial infarction and normal N-terminal pro-brain natriuretic peptide levels by N-terminal pro-atrial natriuretic peptide.
    Jarai R; Iordanova N; Jarai R; Raffetseder A; Woloszczuk W; Gyöngyösi M; Geyer G; Wojta J; Huber K
    Eur Heart J; 2005 Feb; 26(3):250-6. PubMed ID: 15618049
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparable increase of B-type natriuretic peptide and amino-terminal pro-B-type natriuretic peptide levels in patients with severe sepsis, septic shock, and acute heart failure.
    Rudiger A; Gasser S; Fischler M; Hornemann T; von Eckardstein A; Maggiorini M
    Crit Care Med; 2006 Aug; 34(8):2140-4. PubMed ID: 16763507
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Complementary prognostic value of cystatin C, N-terminal pro-B-type natriuretic Peptide and cardiac troponin T in patients with acute heart failure.
    Manzano-Fernández S; Boronat-Garcia M; Albaladejo-Otón MD; Pastor P; Garrido IP; Pastor-Pérez FJ; Martínez-Hernández P; Valdés M; Pascual-Figal DA
    Am J Cardiol; 2009 Jun; 103(12):1753-9. PubMed ID: 19539088
    [TBL] [Abstract][Full Text] [Related]  

  • 13. N-terminal pro-brain natriuretic peptide (NT-proBNP) in healthy blood donors and in patients from general practitioners with and without a diagnosis of cardiac disease.
    Hess G; Runkel S; Zdunek D; Hitzler WE
    Clin Lab; 2005; 51(3-4):167-72. PubMed ID: 15819172
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Cirrhotic cardiomyopathy: increased circulating pro-brain natriuretic peptide and brain natriuretic peptide in cirrhosis].
    Gøtze JP; Henriksen JH; Fuglsang S; Christensen E; Bendtsen F; Møller S
    Ugeskr Laeger; 2004 Aug; 166(35):2999-3002. PubMed ID: 15387012
    [No Abstract]   [Full Text] [Related]  

  • 15. Circulating erythropoietin levels and prognosis in patients with congestive heart failure: comparison with neurohormonal and inflammatory markers.
    George J; Patal S; Wexler D; Abashidze A; Shmilovich H; Barak T; Sheps D; Keren G
    Arch Intern Med; 2005 Jun; 165(11):1304-9. PubMed ID: 15956012
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evolution of amino-terminal pro-B type natriuretic peptide testing in heart failure.
    Januzzi JL; Bayes-Genis A
    Drug News Perspect; 2009 Jun; 22(5):267-73. PubMed ID: 19609464
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Usefulness of N-terminal pro-brain natriuretic Peptide and brain natriuretic peptide to predict cardiovascular outcomes in patients with heart failure and preserved left ventricular ejection fraction.
    Grewal J; McKelvie RS; Persson H; Tait P; Carlsson J; Swedberg K; Ostergren J; Lonn E
    Am J Cardiol; 2008 Sep; 102(6):733-7. PubMed ID: 18773998
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Utility of brain natriuretic peptide to predict right ventricular dysfunction and clinical outcome in patients with acute pulmonary embolism.
    Krüger S; Merx MW; Graf J
    Circulation; 2003 Sep; 108(13):e94; author reply e94-5. PubMed ID: 14517156
    [No Abstract]   [Full Text] [Related]  

  • 19. Interpretation of amino-terminal pro-brain natriuretic peptide levels in the HPS and the CORONA study.
    Cleland JG; Squire I; Ng L
    J Am Coll Cardiol; 2008 Sep; 52(13):1104-5. PubMed ID: 18848145
    [No Abstract]   [Full Text] [Related]  

  • 20. Plasma brain natriuretic peptide as an indicator of left ventricular systolic function and long-term survival after acute myocardial infarction.
    Anker SD; Coats AJ
    Circulation; 1997 Jan; 95(2):538-9. PubMed ID: 9008480
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.